Position in HELP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$247,622
-$144,453 QoQ
Shares Held
51,588
+7.6% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HELP Over Time
Shares Held
Position Value (USD)
Derivatives in HELP
reported options exposure · as of Mar 31, 2026CallValue
$432,000
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. HELP ranks #315 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in HELP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $432,000 | 90,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $247,622 | 51,588 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $392,075 | 47,931 | Shares | Defined | 2026-03-25 | |
| 2025-12-31 | $736,200 | 90,000 | Call | Defined | 2026-03-25 | |
| No filing history on record for this holder in this stock. | ||||||